Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer
European Journal of Cancer · 2026-11 · 248 · 117077
DOI: 10.1016/j.ejca.2026.117077 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Stefano Tancredi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland; Swiss School of Public Health (SSPH+), Zurich, Switzerla…. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland; Swiss School of Public Health (SSPH+), Zurich, Switzerland. Electronic address: stefano.tancredi@unifr.ch.
- Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland; Swiss School of Public Health (SSPH+), Zurich, Switzerland; School of Population and Global Health, McGill University, Montrea…
Zitieren
APA
Tancredi, S., & Chiolero, A. (2026). Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer. European Journal of Cancer, 248, 117077. https://doi.org/10.1016/j.ejca.2026.117077
Vancouver
Tancredi S, Chiolero A. Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer. European Journal of Cancer. 2026;248:117077. doi:10.1016/j.ejca.2026.117077
BibTeX
@article{Tancredi2026,
author = {Tancredi, Stefano and Chiolero, Arnaud},
title = {Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117077},
doi = {10.1016/j.ejca.2026.117077}
}
EUVIMED